Language

News topic

Active ingredient ATORVASTATIN

Current shortage notices for the active ingredient ATORVASTATIN, structured by product, country and reporting period.

12 notices

← All shortages

What the ATORVASTATIN notices indicate for the supply chain

The 12 consolidated notices from Czechia, Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Czechia

ATORVASTATIN RATIOPHARM 40MG TBL FLM 90 I

Active ingredient: ATORVASTATIN

View notice details →
Belgium

Atorvastatin Sandoz 10 mg film-coat. tabl. 100

Active ingredient: Atorvastatin

View notice details →
Belgium

Atorvastatin HCS 80 mg film-coat. tabl. 100

Active ingredient: Atorvastatin

View notice details →
Belgium

Atorvastatine Teva Pharma 40 mg (Orifarm) film-coat. tabl. 100

Active ingredient: Atorvastatin

View notice details →
Belgium

Lipitor 40 mg film-coat. tabl. 100 (100 x 1) UD

Active ingredient: Atorvastatin

View notice details →